When Pfizer came to set up its Twitter account in 2009, the social network was already a big deal, with users sending 100,000 tweets per hour when Michael Jackson died. Arriving late to the party meant the @Pfizer handle was already taken. Now, four years later, Pfizer has finally claimed the account.
Life science vendors face a balancing act when using social media. Giving users the hard sell will bring rejection and reflect badly on the company, but a softly-softly plan might not be noticed at all. Fortunately for vendors, a survey suggests scientists are increasingly accepting of companies on Facebook and Twitter.
The FDA has moved tentatively into the world of smartphones and social media, with its guidance often lagging behind industry expectations and its own activities being grown carefully. These in-house initiatives are now due to gain a new component. The FDA is working on a drug shortages smartphone app.
A stockbroker who took to his Facebook page to sound off in reaction to a critical online report last year regarding Arena Pharmaceuticals has been fined $5,000 for the outburst via social media.
Clinicians have found help from a new mobile app to gauge risks of coronary events in patients with heart disease, guiding them in designing treatment plans.
Treato CEO Ido Hadari has been trying to convince pharma companies that his startup's software offers advances from so-called "social media listening" applications.
I'm tackling a new career challenge. Next month I plan to join Novartis Institutes for BioMedical Research (NIBR) in Cambridge, MA, to manage social media. It means that two weeks from today I will end a thrilling experience as executive editor of the life sciences group at FierceMarkets.
When Sanofi began work on its mobile iBGStar glucose monitor three years ago, Apple's iPhone was the dominant smartphone on the market. And last year the French drug giant released the glucose monitor only for iPhone and iPod Touch devices, PMLive reported.
AstraZeneca has sponsored a web portal that features videos of breast-cancer patient testimonials, becoming one of the latest drugmakers to provide online content to target patient populations.
Time is at a premium. But, Omar Ishrak told FierceMedicalDevices, Twitter has helped him enhance his role as Medtronic's leader and as a stakeholder in the healthcare industry.